Wednesday, October 12, 2022 9:23:06 PM
I read a post on this board stated that Relief Therapeutics would be in talks of a phase 2 trial with Aviptadil (I assume inhaler version) for 2023. My question is why phase 2 instead of phase 3? To me the last trial was totally unfair by FDA. The length of the trial should have been longer (at least 7 days)! Why is the NIH so slow releasing the trial data ? Im sorry but I'm frustrated with the FDA! I'm having problems getting into clinical trials. They are wanting histological proof of sarcoidosis . My biopsies showed granuloma cells with sparse fibrosis. So it was inconclusive! I have all the symptoms of sarcoidosis including the horrible plaques! Oh well sorry to vent. ....
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM